Tritonix.ai

News / Taiwan / cnyes

Tanvex BioPharma August Revenue Skyrockets 210% YoY

Health Technology · Biotechnology · cnyes · 2026-09-10

6541

Tanvex BioPharma (6541) reported a 210.14% year-over-year revenue surge for August 2026, with cumulative year-to-date growth reaching 250.13%.

What Happened

Revenue Performance: Tanvex BioPharma (6541) announced August 2026 revenue of NT$73.18 million, representing a substantial year-over-year growth of 210.14% and a 36.06% monthly increase.

Year-to-Date Results: The company's cumulative revenue for the first eight months of 2026 reached NT$480 million, marking a year-to-date growth rate of 250.13%.

Market Performance: With a current share price of NT$31.55, the stock rose 0.96% over the last five days, outperforming the biotech and healthcare sector index which declined by 1.69%.

Business Profile: Tanvex BioPharma is primarily engaged in the research, development, manufacturing, and commercialization of biosimilars and novel drugs.

Read original

More in Health Technology

Rare Disease Families Face Regulatory Hurdles in Quest for Gene Therapy Access

Health Technology · cnbc · 2026-09-10

The struggle of the Stecker family to secure gene therapy for their son highlights the systemic challenges and ethical dilemmas in treating rare childhood diseases.

GILD

Alvogen's Subsidiary Lotus Reports 81% Surge in August Revenue

Health Technology · cnyes · 2026-09-10

Lotus Pharmaceutical reported August 2026 revenue of NT$2.11 billion, an 81.68% YoY increase, with cumulative year-to-date growth reaching nearly 70%.

1795

Lotus Pharmaceutical Reports 81.6% Revenue Surge in August, Driven by Alvogen Integration

Health Technology · economic_daily · 2026-09-10

Lotus Pharmaceutical announced an 81.67% year-over-year revenue increase for August, reaching NT$2.107 billion, fueled by strong B2B growth and the Alvogen merger.

1795

Latest in Taiwan

Chunghwa Telecom Reclaims Top Spot in Monthly Earnings Among Taiwan's Big Three

Communications · cnyes · 2026-09-10

Chunghwa Telecom reported a strong August with EPS of NT$0.57, driven by robust ICT business growth, surpassing its local rivals in monthly profitability.

2412, 3045, 4904, 6214

FSC to Review Decades-Old Regulations Following Wiwynn Fractional Share Dispute

Electronic Technology · cnyes · 2026-09-10

The Taiwan FSC is set to review a 30-year-old regulation on fractional share cash payouts after investor backlash over Wiwynn's recent dividend distribution.

6669

Cement Giants Diverge in August: TCC Revenue Climbs While Asia Cement Slips

Non-Energy Minerals · economic_daily · 2026-09-10

TCC reported a 10.65% year-over-year revenue increase in August driven by European operations and energy storage, while Asia Cement saw a 1.3% decline due to weak demand in China.

Chang Cheng Reports 189% Year-on-Year Revenue Growth for August

Electronic Technology · cnyes · 2026-09-10

Chang Cheng announced August revenue of NT$10.55 million, marking a significant 189.12% year-on-year increase, despite a month-on-month decline.

8097